A report published by the website Peter Sweden, also known as Freedom Corner with Peter Sweden, claims that a Greek court orders compensation in vaccine-related death case to the family of a woman who died following a COVID-19 vaccination.
According to the report, the court ruled in favour of the family, finding a link between the woman’s death and the AstraZeneca vaccine administered as part of Greece’s national vaccination programme.
The woman is said to have developed a rare blood clotting condition, known as vaccine-induced immune thrombotic thrombocytopenia (VITT), which has been associated in some cases with certain COVID-19 vaccines.
The court reportedly determined that there was a direct causal connection between the vaccination and her death, noting that she had no prior underlying health conditions.
A key element of the ruling, as described in the report, is that responsibility was attributed to the state, given that the vaccination took place within the framework of a national public health campaign. Arguments from the defence that the vaccination was voluntary were not upheld.
The pharmaceutical company AstraZeneca was not found liable in the case.
According to the same source, the total compensation awarded amounted to €300,000, with €120,000 allocated to the husband and €90,000 to each of the couple’s two daughters.
While the case is described as significant, it has received limited coverage in mainstream media, and further independent confirmation or official court documentation would provide additional context to the ruling.
A Greek court has awarded €300,000 in compensation to the family of a woman whose death was found to be linked to the AstraZeneca COVID-19 vaccine, marking a significant legal development in cases involving vaccine-related adverse events. The ruling determined that the state bore responsibility, as the vaccination was administered במסגרת Greece’s national public health campaign, despite arguments that participation was voluntary. Medical evidence presented to the court identified a direct connection between the vaccine and a rare clotting condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT). While the decision underscores that compensation may be granted in exceptional cases where causation is clearly established, it does not alter the broader medical consensus on vaccine safety.
